» Download Public Reports
11 reports
- Industry report
- March 2010
- 5 pages
- by Research Paper
... Developed as alternative vehicles for the safe and economic production of pharmaceutical proteins including therapeutic recombinant monoclonal antibodies.5 The suitability of maize as a production host ...
February 2009
... P-ipv-hib acellular pentavalent vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and hib disease 6 11 benefits of pentaxim As a combination vaccine for the vaccinee reduction in number of injections ...
February 2009
... Firms consider developing country market as small (in $ terms) and often unpredictable Profitability of these markets is limited As a result poorest countries may not have access to newest vaccines ...
April 2010
... Infectious disease vaccine and antibody business Consistent sales growth and profitable as of 2008, following successful integration and turn around of acquisitions Growth potential for existing products ...
April 2010
... Advantages of mend's as a consequence, a qms was designed and implemented upfront inhalable drugs and vaccines are improved efficacy and reduced to first meet the requirements of glp, but that could ...
September 2011
... Of a fermentation technology for the production of human recombinant proteins 4. Halodurans development & optimization of a recombinant technology for the production of therapeutic peptides. 5. enzyme technologies ...
April 2012
... Seed for stable storage of the material as a pre-pandemic strategy. Results for both transient and transgenic expression systems the highest accumulation of full-length h5 protein occurred ...